Navigation Links
Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Date:9/5/2007

a's lead anticancer drug, is a novel targeted therapy that blocks the production of Bcl-2, a protein that appears to be a fundamental cause of cancer treatment resistance. By knocking down Bcl-2, Genasense may enhance the effectiveness of chemotherapy in patients with advanced melanoma. Genasense in melanoma has Orphan Drug designations in Australia and the U.S., along with Fast Track designation in the U.S.

In its initial Phase 3 trial, Genta performed the largest randomized controlled trial that has ever been conducted in patients with advanced melanoma. In that trial, 771 patients were randomly assigned to receive chemotherapy with DTIC alone or in combination with Genasense. A scientific article that describes efficacy and safety results from this study can be accessed at: http://www.jco.org/cgi/content/abstract/JCO.2006.06.0483v1.

In that trial, patients were prospectively stratified according to levels of a blood enzyme known as LDH. Further analysis of this study showed that maximum benefit accrued to patients whose LDH biomarker did not exceed 80% of the upper limit of normal. Efficacy results in this group of 274 patients, which are the focus of the confirmatory AGENDA trial, are displayed in the table below. (The hazard ratios indicate that the addition of Genasense to DTIC was associated with a 42% reduction in the risk of disease progression and a 36% reduction in risk of death.)

Endpoint Genasense/DTIC DTIC Hazard P

Ratio

Overall response 20.8 % 7.2 % 0.002

Durable response 10.7 % 2.4 % 0.007

Progression-free survival,

median 3.6 mos. 1.6 mos. 0.58 <0.0001

Overall survival, median 12.3 mos. 9.9 mos. 0.64 0.0009

A
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
2. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
3. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
4. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
5. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
6. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
7. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
8. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Today, Avantium announced the,appointment of Gunnar ... pharmaceutical,business. Gunnar Staaf previously worked at Serentis ... Company, in a range of commercial and ... in Avantium,s plan to,spin-out its pharmaceutical business. ... company based on its offering of proprietary,crystallization ...
(Date:12/16/2009)... Dec. 16 GlaxoSmithKline plc [GSK] (NYSE: ... announced an exclusive licensing agreement in the United ... of NB-001, a novel, patented compound representing the ... Developed by NanoBio, NB-001 provides significant antimicrobial activity ... herpes labialis . ,, Cold sores are ...
(Date:12/16/2009)... AARP Illinois Disappointed By Senate Vote Against Lower ... The U.S. Senate on Tuesday night ... Affordable Care Act that would help make prescription ... and legal importation of lower priced drugs from ... and sponsored by Senators Dorgan, Snowe, McCain, Grassley ...
Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2AARP Illinois Key Vote News Alert 2Clinical Studies Validate Cancer Gene Delivery Platform 3A Landmark Publication Confirms Rexin G Effectively Targets Metastatic Cancers and Improves P 49657 1Clinical Studies Validate Cancer Gene Delivery Platform 3A Landmark Publication Confirms Rexin G Effectively Targets Metastatic Cancers and Improves P 49657 2Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 1Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 2Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 3Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan 12731 4PhRMA Statement on AARP White House Press Conference 12729 1PhRMA Statement on AARP White House Press Conference 12729 2
(Date:12/17/2009)... a revealing portrait of the nearly one-in-three American adults who serve ... ... December 17, 2009 -- The National Alliance on Mental Illness (NAMI) ... which offers a revealing portrait of the nearly one-in-three American adults ... based on interviews with 1,480 caregivers chosen at random and offers ...
(Date:12/17/2009)... over the past three years and what has driven these changes ... ... Morehead, the human capital research firm, will host a webinar titled ... free hour-long webinar will be broadcast on Wednesday, January 27, 2010 ... Morehead’s SVP, Consulting Services and Trevor Byrd, Ph.D., a Morehead Consultant, ...
(Date:12/17/2009)... businesses listed on search engines like Google Local and in front ... presence with SEO Local Registration service offered by New Orleans based ... ... December 17, 2009 -- In order to be competitive locally and ... a listing on a local map section in a major search ...
(Date:12/17/2009)... will provide Baptist with on-going Healthcare Cost/Risk Analysis reports, activity ... health improvements as it translates toward reduced claim costs and ... , ... Jacksonville, FL ... health risk management company specializing in clinical/claims based cost risk ...
(Date:12/17/2009)... marketing techniques, life coaching company puts free i-phone & ... http://itunes.apple.com/us/app/attainment-life-management/id345691804?mt=8 . For the Free download. , ... ... -- Utah based Attainment Life Management & Coaching is ... everything in life simplified into one little hand held ...
Breaking Medicine News(10 mins):Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review" 2Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2
... African ministers have formulated a plan to combat the ... continent. //The plan was agreed to during the one-day ... of ministers in charge of agriculture, health, livestock, environment ... of the meeting said that the ministers "examined and ...
... the last detail. But the mobile phone messages proved their ... in the crime. ,The murder last Sunday of 30-year-old ... Kerala's Idukki district had been scripted by his wife, 24-year-old ... their honeymoon. ,The couple, who are from Chennai, ...
... Recent research has revelaed that it is better to ... it to flow into the sewer, from an environmental// ... University of Technology researcher Jac Wilsenach, who on Monday ... this research subject. ,Wilsenach estimates that substantial ...
... in the age of baby boomers. This has brought ... the scenario. Patients are// now seeking new therapy and ... ED, known as PDE-5 inhibitors, have revolutionized treatment for ... series of studies, Jack Mydlo, MD, professor and chair ...
... reduction in the bone mass and density increasing the susceptibility ... approximately 10 million Americans above the age of ... (HSPH), scientists have discovered that the removal of a protein, ... their overall bone mass. The results may have profound implications ...
... Toronto's Department of Nutritional Sciences say that the glycemic ... small or large portions are consumed. This should come ... GI was developed 25 years ago at U of ... table has become an important tool for the management ...
Other Medicine News:Health News:Mobile Phone Messages Assists in Unraveling Murder Mystery 2Health News:Urine Purification to Revolutionize Waste Water Management 2Health News:Non Surgical Medication Drugs Prove To Be Effective In Treating ED 2Health News:Research Identifies Osteoporosis Controlling Protein 2Health News:Glycemic Index Works For Diabetes Patients 2
Hydrodissection / Aspiration Cannula, 25 g. Angled with left hook. 10 mm angled shaft with 2.5 mm left hook tip. Overall length 20 mm. 5/box....
Irrigating Capsulorhexis Cystotome. Formed angled tip, 27 g. Overall length 16 mm. 5/box....
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Retrobulbar Needle, 23 g. Atkinson style bevel. Overall length 38 mm. 5/box....
Medicine Products: